DEIRDRE CLARK: Open Payments
NPI 1811251713 · WILLIMANTIC, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 11 payments from 6 companies in 2025. Trend: 2023 $122 · 2024 $280 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $72 |
| Actelion Pharmaceuticals US, Inc. | 3 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| PFIZER INC. | 1 | $25 |
Products named: Repatha, JARDIANCE, UPTRAVI, CAMZYOS, LEQVIO, VYNDAQEL, OPSUMIT.
Industry payments across CT — which companies pay providers there.
